Lundi, 26 Octobre 2020
Dernières nouvelles
Principale » Bristol-Myers Squibb Company (BMY), Avon Products, Inc. (AVP) — Investors Focused Movers

Bristol-Myers Squibb Company (BMY), Avon Products, Inc. (AVP) — Investors Focused Movers

26 Juillet 2017

Breton Hill Capital Ltd. now controls 28,614 shares with a value of $1,594,000. About 1.97M shares traded. Ultra Clean Holdings Inc (UCTT) has risen 320.86% since July 24, 2016 and is uptrending. (BMY) stake by 28.73% reported in 2016Q4 SEC filing. (BMY)'s stock declined 1.04%. The fund owned 7,116 shares of the biopharmaceutical company's stock at the end of the second quarter. Dodge Cox has invested 1.17% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). The stock rose 0.72% or $0.4 reaching $56.

Media coverage about Bristol-Myers Squibb (NYSE:BMY) has trended somewhat positive this week, Accern Sentiment reports. It has underperformed by 16.70% the S&P500.

Since February 27, 2017, it had 1 insider buy, and 6 selling transactions for $9.91 million activity. On Thursday, May 11 the insider Aryeh Jason sold $4.13M. Finally, William Blair restated an outperform rating on shares of Bristol-Myers Squibb in a research report on Monday, June 26th. Another trade for 15,000 shares valued at $851,220 was made by Schmukler Louis S on Tuesday, March 14. Therefore 80% are positive. Jefferies Group LLC reaffirmed a "buy" rating and set a $66.00 price objective (up from $64.00) on shares of Bristol-Myers Squibb in a research report on Saturday, March 11th. BidaskClub upgraded shares of Bristol-Myers Squibb from a "hold" rating to a "buy" rating in a report on Tuesday, June 27th.

Analysts on average have given a price target of $57.59 to Bristol-Myers Squibb Company (BMY) stock. The firm earned "Buy" rating on Thursday, November 19 by TH Capital.

11/07/2016 - Bristol-Myers Squibb Company had its " rating reiterated by analysts at Citigroup. Bristol-Myers Squibb presently has a consensus rating of "Hold" and an average price target of $63.26. The stock has "Hold" rating by Jefferies on Thursday, July 14. For the past 5 years, the stock's EPS growth has been almost -16.70%.

Investors sentiment decreased to 0.97 in Q4 2016.

Dollar Index Falls to 13-month Low on Fed Worries
The US dollar nudged higher and Asian equities opened mixed with trading muted ahead of the US Federal Reserve's policy decision. The dollar index was showing one of the lowest performances it has, while its euro counterpart hovers around the two-year high.

The SMA20 for the stock is at -0.04 percent, SMA50 stands at 1.4 percent, while SMA200 is 1.66 Percent.

Want to see what other hedge funds are holding BMY?

These funds have also shifted positions in (BMY). Natixis reported 301,236 shares. Aviva Public Limited Com has invested 0.43% in Bristol-Myers Squibb Co (NYSE:BMY).

July 17 investment analysts at Deutsche Bank kept the company rating at "Hold" and lowered the price expectation from $65.00 to $55.00. 613 were reported by Baystate Wealth Mngmt Ltd Com. Miracle Mile Advsrs accumulated 0.19% or 13,747 shares. Sivik Global Ltd Limited Liability Company has 125,000 shares for 3.49% of their portfolio. Boys Arnold holds 29,710 shares or 0.32% of its portfolio. The institutional investor held 165,299 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $9.66M, up from 12,321 at the end of the previous reported quarter. Another trade for 8,096 shares valued at $463,779 was sold by Caldarella Joseph C. $681,240 worth of Bristol-Myers Squibb Co (NYSE:BMY) shares were bought by Samuels Theodore R. II.

235K shares changed hands on Tuesday. 329,697 were reported by Ing Groep Nv. Crestwood Advisors Group LLC purchased a new position in shares of Bristol-Myers Squibb during the first quarter worth approximately $116,000. The institutional ownership stake in the corporation is 89.50%. Agenus Inc (NASDAQ:AGEN) was raised too. During the same quarter in the prior year, the company posted $0.74 earnings per share. A beta of 1.0 tells you that a stock has been going up and down with the overall stock market. The biopharmaceutical company reported $0.84 EPS for the quarter, beating the consensus estimate of $0.72 by $0.12. Its down 0.16, from 1.13 in 2016Q3. It turned negative, as 104 investors sold QCOM shares while 514 reduced holdings. Symphony Asset Management owns 22,076 shares. Cleararc Cap stated it has 37,542 shares. Glg Llc accumulated 0.04% or 19,573 shares. Pioneer, Massachusetts-based fund reported 110,498 shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh expanded its holdings by buying 18,547 shares an increase of 19.5% in the quarter. Argent Tru owns 53,459 shares for 0.91% of their portfolio. It also reduced Comcast Corp New (NASDAQ:CMCSA) stake by 11,005 shares and now owns 206,678 shares. The firm has price to sales ratio of 4.63 and its price to book per share was 6.41. S&Co Inc who had been investing in Bristol for a number of months, seems to be bullish on the $91.94B market cap company. Goldman Sachs Grp Inc has 0.02% invested in CVB Financial Corp. Riverpoint Ltd reported 0.08% stake. The Oregon-based Pacific Ridge Capital Partners Llc has invested 1.94% in the stock. A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range. Qualcomm Inc. had 94 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has "Market Perform" rating given on Monday, January 25 by BMO Capital Markets. FBR Capital maintained IBERIABANK Corp (NASDAQ:IBKC) rating on Wednesday, September 7. The rating was maintained by UBS with "Buy" on Friday, August 19. The firm has "Outperform" rating given on Wednesday, April 26 by RBC Capital Markets. The insider ANDREOTTI LAMBERTO sold $1.91M. About 200 shares traded. $428,240 worth of stock was sold by HIGGINS JOHN L on Wednesday, March 8. That's a potential 23.05 gain from where (NYSE:COP) has been trading recently. VAN LOKEREN MARY ANN had sold 3,880 shares worth $142,317.

Bristol-Myers Squibb Company (BMY), Avon Products, Inc. (AVP) — Investors Focused Movers